2Joussen AM,Poulaki V,Le ML,et al.A central role for inflammation in the pathogenesis of diabetic retinopathy[J].FASEB,2004,18(12):1450-1452. 被引量：1
3Xu Q,Qaum T,Adamis AP.Sensitive blood-retinal barrier breakdown quantitation using Evans blue[J].Invest Ophthalmol Vis Sci,2001,42:789-794. 被引量：1
4Jonas JB.Intraocular availability of triamcinolone acetonide after intravitreal injection[J].Am J Ophthalmol,2004,137(3):560-562. 被引量：1
5McCuen BW,2nd,Bessler M,Tano Y,et al.The lack of toxicity of intravitreally administered triamcinolone acetonide[J].Am J Ophthalmol,1981,91(6):785-788. 被引量：1
6Jaissle GB,Szurman P,Bartz-Schmidt KU.Ocular side effects and complications of intravitreal triamcinolone acetonide injection[J].Ophthalmologe,2004,101(2):121-128. 被引量：1
7Jonas JB,Kreissig I,Sofker A,et al.Intravitreal injection of triamcinolone for diffuse diabetic macular edema[J].Arch Ophthalmol,2003,121:57-61. 被引量：1
